Quantifying adverse drug events : are systematic reviews the answer?
Etminan Mahyar, Carleton Bruce, Rochon Paula A·Drug safety
Quantifying adverse drug events (ADEs) is critical to clinicians, consumers and policy makers. Most ADE information comes from large clinical trials. Systematic reviews have become a popular tool in quantifying the efficacy of different therapeutic interventions and ADE data collected in randomised trials may be helpfu…